Zichen Bian

发表

Immune response drives outcomes in prostate cancer: implications for immunotherapy

C. Liang, Yujie Zhou, Jialin Meng, 2020, bioRxiv.

Immunological alterations in patients with chronic prostatitis/chronic pelvic pain syndrome and experimental autoimmune prostatitis model: A systematic review and meta-analysis.

C. Liang, Jialin Meng, Zichen Bian, 2021, Cytokine.

Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based classifier for recurrence‐free survival predicting of prostate cancer

C. Liang, Jialin Meng, Yi Liu, 2022, Journal of cellular and molecular medicine.

Establishment and Validation of Coagulation Factor-Based Nomogram for Predicting the Recurrence-Free Survival of Prostate Cancer

C. Liang, Jialin Meng, Jun Zhou, 2021, Urologia Internationalis.

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy

C. Liang, Jialin Meng, Meng Zhang, 2022, Computational and structural biotechnology journal.

Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis

C. Liang, Zichen Bian, C. Jin, 2021, Molecular and Cellular Biochemistry.

Radial Extracorporeal Shock Wave Therapy Combined with Resveratrol Derivative Alleviates Chronic Nonbacterial Prostatitis in Rats.

C. Liang, Zichen Bian, Zhengyao Song, 2022, Inflammation.

Efficacy and safety evaluation of low-intensity extracorporeal shock wave therapy on prostatitis-like symptoms: An open-label, single-arm trial.

C. Liang, Zhiping Wang, Jialin Meng, 2021, Andrologia.

Dietary habits and lifestyle related to the effectiveness of low‐intensity extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome‐like symptoms: Initial results

C. Liang, Jialin Meng, Meng Zhang, 2022, Andrologia.

Genetic Polymorphisms of IFNG, IFNGR1, and Androgen Receptor and Chronic Prostatitis/Chronic Pelvic Pain Syndrome in a Chinese Han Population

C. Liang, Fan Mo, Zichen Bian, 2021, Disease markers.

Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients

C. Liang, Jialin Meng, Jun Zhou, 2021, International journal of medical sciences.

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer

C. Liang, Jialin Meng, Jun Zhou, 2020, Cancer management and research.

In silico validation of a new classifier, PCSCGier, for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets

C. Liang, Jialin Meng, Jun Zhou, 2023, Clinical and translational medicine.